Faze Three Intrinsic Value
Faze Three (FAZE3Q) median intrinsic value is ₹193.02 from 4 valuation models (range ₹175–₹276), vs current price ₹482.55 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Also explore FAZE3Q share price data to track price trends across different timeframes.
FAZE3Q Valuation Methods Summary — DCF, Graham Number & P/E
Faze Three intrinsic value across 4 models vs current price ₹482.55 — upside/downside and value range per method. Browse FAZE3Q complete financial statements for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹175.00 | ₹157.50 - ₹192.50 | -63.7% | Book Value/Share: ₹175.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹276.00 | ₹248.40 - ₹303.60 | -42.8% | Revenue/Share: ₹345.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹193.02 | ₹173.72 - ₹212.32 | -60.0% | EBITDA: ₹24.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹193.02 | ₹154.42 - ₹231.62 | -60.0% | CF Growth: 10.1%, Discount: 15% |
FAZE3Q Intrinsic Value vs Market Price — All Valuation Models
Faze Three fair value range ₹175–₹276 vs current market price ₹482.55 across 4 valuation models. For current market price and key ratios, visit Faze Three stock price NSE.
FAZE3Q Intrinsic Value Analysis — Undervalued or Overvalued?
Faze Three median intrinsic value ₹193.02, current price ₹482.55 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.
What is the intrinsic value of FAZE3Q?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Faze Three (FAZE3Q) is ₹193.02 (median value). With the current market price of ₹482.55, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹175.00 to ₹276.00, indicating ₹175.00 - ₹276.00.
Is FAZE3Q undervalued or overvalued?
Based on our multi-method analysis, Faze Three (FAZE3Q) appears to be trading above calculated value by approximately 60.0%.
FAZE3Q Financial Health — Key Ratios vs Industry Benchmarks
Faze Three financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 20.94 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -4.8% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 3.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.21x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
FAZE3Q Cash Flow Quality — Operating & Free Cash Flow
Faze Three operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹12 Cr | ₹-10 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹37 Cr | ₹15 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹110 Cr | ₹88 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-7 Cr | ₹-33 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹9 Cr | ₹-18 Cr | Positive Operating Cash Flow | 6/10 |